Amanta Healthcare Stock: price and insider trades · India
No insider purchase over the last 90 days. The latest, by Jitendrakumar Jashbhai Patel, was filed 22 Jun 2026.
Amanta Healthcare: what insiders have been doing
Amanta Healthcare belongs to the Health Care sector. Filings by its managers are published through SEBI (PIT + SAST). From 7 November 2025 to 7 November 2026, the disclosure feed for Amanta Healthcare logged 10 filings by 5 insiders.
The record shows 2 purchases on the open market worth €29k, made by 2 insiders, against 1 sale worth €7,195 by 1 insider. Purchases outweigh sales by €22k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Jitendrakumar Jashbhai Patel filed the largest purchase, €22k, on 22 June 2026, which represents 0.035% of the company's market value. On the buying side, the filings list 1 major shareholder and 1 senior executive among the declarants.
For context, the typical company on the same exchange (median of 1,913 companies) published 4 filings over the same period, against 10 filings here. Over the whole record (from 2026), the tally stands at 2 purchases and 1 sale.
In all, 1 purchase was made within 30 days of a purchase by another insider of the company. Purchases made close together by different insiders form what is called a cluster. The last insider purchase was made public on 22 June 2026, 140 days ago. Most trades are made public on the day they happen. That lag is the time during which only the insider knows about the trade.
Other companies in the same sector with recent insider buying flagged by our signals: Dynavox Group AB and Vetoquinol SA. Source: insider filings from SEBI (PIT + SAST). Past trades are no guide to future returns.
Who traded when
BuySaleSince the insiders bought
- +22.3%Entry ₹160.50 · Close 05 Nov 2026 ₹196.30
- +29.6%Entry ₹151.50 · Close 05 Nov 2026 ₹196.30
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2026FY ended March 2026 · cache
- 300,150 shares@ ₹180.00EquityOff MarketSEBI:564063693cc91993017bcdeb70286146f0f2a256
- 1,732,763 shares0EquityGiftSEBI:e268aa1dbc45b8b8e57fcf9dc23157ff03a07e78
- 150,400 shares@ ₹190.000.39% mcap96.8% of flowEquityInter-se-TransferSEBI:2353455a2d9b2fc62e83268bae541322d681a135
- 150,400 shares@ ₹190.000.39% mcap100.0% of flowEquityInter-se-TransferSEBI:675db007d4637e70334262525f992aa5fb970614
- 1,000 shares-Off Market / Inter se transferSEBI:7318079c0bcf36ff193aeac3efd348a96ea5b47d
- 1,000 shares@ ₹160.000.0022% mcap18.7% of flowEquityOff MarketSEBI:0552b63d2c99ad827d11189a1d04d6e1d9c3d2aa
- 1,000 shares@ ₹160.000.0022% mcap17.0% of flowEquityOff MarketSEBI:78e3739ee6f189602e166574d52dcb30e250045c
- 16,200 shares@ ₹150.000.035% mcap100.0% of flowEquity SharesMarket PurchaseSEBI:0e5737dd8c2c5d2deaa4b5bb387e747de02f6314Canonical exit: 20 Sept 2026 (T+90)
- 4,635 shares@ ₹150.300.0100% mcap81.3% of flowEquityMarket PurchaseSEBI:efb2175e175f61ca944294e4ea091390e0ea693aCanonical exit: 16 Sept 2026 (T+90)
- 5,000 shares@ ₹157.3083.0% of flowEquity SharesMarket SaleSEBI:8db8ac1acdfae450e9c0dd9bd7a980c1020fc69f
10 of 10 declarations
About Amanta Healthcare
Amanta Healthcare is a company engaged in the manufacturing and distribution of pharmaceutical products. It is listed on the XBOM market.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
